4/A//SEC Filing
ANDREEFF DANE 4/A
Accession 0001140361-24-008177
CIK 0001610853other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:06 PM ET
Size
11.3 KB
Accession
0001140361-24-008177
Insider Transaction Report
Form 4/AAmended
ANDREEFF DANE
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2023-11-30$6.37/sh+641$4,083→ 1,239 total(indirect: See footnote) - Purchase
Common Stock
2023-12-01$6.45/sh+643$4,146→ 1,882 total(indirect: See footnote)
Holdings
- 9,991(indirect: See footnote)
Common Stock
- 13,684(indirect: See footnote)
Common Stock
- 29
Common Stock
Footnotes (5)
- [F1]On December 4, 2023, the reporting person filed a Form 4 (the "Original Form 4") which incorrectly reported that these shares were purchased by Maple Leaf Discovery I, LP ("MLD I"), when in fact they were purchased by Maple Leaf Offshore, Ltd. ("MLO"). This amendment is being filed to correctly reflect the purchases and the amount of shares held by both MLD I and MLO following the reported transactions.
- [F2]As a result of a rounding error following a reverse stock split by the Issuer, the Original Form 4 incorrectly stated the amount of securities beneficially owned. The amounts reported on this amendment have been corrected to reflect the actual number of shares held at the time of filing the Original Form 4.
- [F3]The shares are held by MLO. The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F4]The shares are held by MLD I. The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F5]The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
Documents
Issuer
HELIUS MEDICAL TECHNOLOGIES, INC.
CIK 0001610853
Entity typeother
Related Parties
1- filerCIK 0001201810
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:06 PM ET
- Size
- 11.3 KB